The Cannabis Society Investor Conference Melbourne (Invite Only)
KARSTENS MELBOURNE, QUEEN STREET, 123, MELBOURNE, 3000
Melbourne VIC, Australia
Victoria
-37.8136276
144.96305759999996
Description
The Cannabis Society is proud to present our Melbourne Investor Conference on July 31st.
We are dedicated to fostering the cannabis community through events, conferences, dinners, & many more. Join us for a unique deal making session and to hear from Industry experts, entrepreneurs, investors and service providers on what is to come in this emerging industry.
TENTATIVE SCHEDULE:
11:00 AM: REGISTRATION
11:45 AM: OPENING REMARKS by The Cannabis Society
12:00 PM: KEYNOTE by Victorian Parliament
12:15 PM: Industry Fireside Chat
12:45 PM: LP Panel Discussion
1:30 PM: Supply Chain Panel Discussion
2:15 PM: Networking and Deal-making
CONFIRMED PARTICIPANTS:
Fiona Patten, Northern Metropolitan Region Member Victorian Parliament’s Legislative Council
Fiona Patten is a Member for Northern Metropolitan Region in the Victorian Parliament’s Legislative Council. Leader of the Reason Party, Fiona was first elected in 2014 and re-elected in 2018.
Since being elected in 2014, Fiona has garnered respect from all sides of the political divide and has worked tirelessly to deliver legislative reforms that many thought impossible. Her achievements include establishing fertility clinic safe access zones, initiating Australia’s largest public inquiry into drug law reform, online e-petitions to Parliament, legalising Uber, securing a trial for Victoria’s first medically supervised injecting centre and initiating the Parliamentary Inquiry that led to Voluntary Assisted Dying laws. As ABC 774’s Jon Faine says: “She is, without doubt, Australia’s most effective legislator.”
Fiona is now working to improve Victoria even further. This term she has already secured Australia’s first Inquiry into Cannabis, an Inquiry into a Legislated Spent Convictions Scheme, and the daily recitation of the Parliamentary Lord’s Prayer is being reviewed by the government. She is also pushing for religious accountability and greater separation of church and state, to legalise sex work and reduce social isolation and loneliness.
Fiona’s decision to run for political office came after 20 years of advocating for the rights of small business owners, sexual health organisations, sexual freedoms and censorship reforms.
Dr Sud Agarwal, Co-Founder and CEO of Cannvalate
Dr Sud Agarwal is the co-founder and chief executive officer of Cannvalate, Australia’s first medically backed, medicinal cannabis company, focused on providing a seamless entry for global licensed producers of medicinal cannabis into the Australian market. He is a former medical director of the Cann Group (ASX:CAN) and has been an adviser to multiple listed/ unlisted companies and governmental bodies in the Medicinal Cannabis space.
Dr Agarwal received his medical qualifications in the United Kingdom before immigrating to Australia in 2001. He has since commercialised, scaled and successfully exited three healthcare businesses and has a track record for seeing business opportunities at their earliest stage, and building high performing teams.
Dr Agarwal is also an experienced property developer who has completed 7 projects comprising residential, commercial and mixed-use projects. As the founder and director of Sterling Property Group, he has proven his ability to achieve excellent design and planning results, manage construction projects and deliver multi-faceted built form outcomes on time, under cost and with superior quality.
A rare combination of extensive medical experience, commercialisation success in several healthcare businesses and a proven track record in property development, positions Dr Agarwal perfectly to lead Cannvalate.
Tim Oates, Co-Founder & Chief Executive Officer, Delta Tetra Consultancy
If you are involved with medical cannabis in Australia, you have likely heard of Delta Tetra Group. As CEO of Delta Tetra since its inception in 2016, Tim has support the complex and nuanced development of the Australian sector.
After spending a number of years in leadership training with Apple Inc., Tim became involved in prominent cannabis-based initiatives throughout the UK & Europe.
Since permanently emigrating to Australia in 2015, Tim continued developing opportunities for himself and those around him, directly related to cannabis policy and operations. Tim has a strong background in client relations, business development and practical cannabis management with an emphasis on people and communications. Through working tirelessly to innovate and progress sensible approaches to cannabis legislation across Europe & Australia, Tim has built applicable and practical knowledge of the global cannabis industry as well as a wealth of experience in pharmaceutical medicinal cannabis and its relating nuances.
As CEO of Australia’s original cannabis specific consultancy firm, Delta Tetra Group, Tim has been immersed in business strategy and commercialisation, regulatory compliance as well as intensive networking and deal flow. With a strong focus on cannabis breeding and cultivation, Tim is able to draw parallels between the ever-changing regulatory space and practical cannabis management.
Elisabetta Faenza, Co-Founder and CEO, LeafCann Group
Member of Australian Institute of Company Directors (MAICD), Deputy Chair Montegu Services Masters International Relations, Dip & Adv. Certificate Clinical Hypnotherapy, Diploma Marketing University of Illinois at Chicago.
Elisabetta’s journey was prompted by a childhood diagnosis of a rare, deadly genetic condition, which led her on a quest to understand how our bodies, medicines, nutrition and the environment interact to switch damaging genes on and off. Before co-founding LeafCann Group, a licenced Medicinal Cannabis company based in Australia and the UK, Elisabetta’s work as a clinical hypnotherapist, corporate speaker and mentor assisted thousands of individuals to change unwanted behaviours, recover from trauma and achieve personal and career goals. In LeafCann, Elisabetta has brought together a talented team of experts from biomedicine, clinical research, quality assurance, education and training, controlled medicinal cannabis cultivation, extraction, policy, project management, facility design, regulatory affairs and IP management. Elisabetta manages a global team on three continents, all working to produce the highest quality Medicinal Cannabis products under GMP.
Tommy Huppert, Founder & CEO, Cannatrek
Start-up entrepreneur and medicinal cannabis health economist, Tommy founded Cannatrek and put in motion it’s "seed to patient" industry strategy, corporate governance and cannabis licensing compliance structure.
A seasoned international CEO with 30 years of business and leadership acumen in pioneering new industries, Tommy has drawn together an expert team of associated alliances, to deliver the Cannatrek blueprint strategy.
Adam Guskich Co founded Medigrowth Australia in 2017 with a vision to create a globally respected medicinal cannabis company. Our mission is to become a global leader and valuable supply chain partner for superior medicinal cannabis extraction, laboratory testing, formulation, cultivation & innovation. A true circular economy from seed to solution.
Together with co founder Todd McClellan, “ we share a resolute belief in medicinal cannabis along with a combined vision for creating a company with the ability to effect substantial positive change in patient wellbeing.” This is the motivational driver for success. Their focus is aligned within four core pillars of the supply chain; Grow, Extract, Test & Research.
Adam will leverage his 20+ years of business experience to execute Medigrowth strategy. He is highly skilled in business operations, negotiation, retail, business to business engagement & relationship management. Adam has been instrumental in creating opportunity for Medigrowth, with the company positioned domestically & internationally with strategic partners ranging from extraction specialists, cannabis health & retail, genetics specialists, and collaboration with educational & University institutions.
Adam is inspired, focussed and driven. He has in depth knowledge and understanding of Australian legislation, licensing and regulation and will combine this knowledge with his unique skill-set to refine business strategy as the domestic and international landscape continues to evolve.
Arjun Chhabra, Chairman and President, Greenfield Medicinal Cannabis
Arjun is a lawyer who specializes in corporate, drug, health, and regulatory law. He has a background in mergers and acquisitions, capital raisings, and corporate governance. Arjun has worked with start-ups and in emerging markets, having worked as a corporate lawyer in Australia, the Asia-Pacific, and the Middle East, and as an investment banker in sub-Saharan Africa. He has worked with Deloitte, Blake Dawson Waldron (now Ashurst), Baker & McKenzie, Clyde & Co, and was the Chief Executive Officer and later Chief Strategy Officer of Anthesis Capital.
Abdul Rehman Mohammad, Co-Founder and Director, Australian Cannabis Laboratories
Rhys Cohen, Director of Cannabis Consulting Australia
CCA helps international and domestic organizations navigate regulated cannabis markets in APAC through assisting with market analysis and entry; import/export; distribution and sales; supply chain partner identification; license and permit applications; media and government relations; and scientific research partnerships. Rhys has worked extensively with the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney. And his industry analysis has been cited by Deloitte Access Economics and the Commonwealth Department of Health.
This listing has no upcoming events
Start:
2019-07-31T11:00:00+10:00
End:
2019-07-31T15:00:00+10:00
Category
Business
Tickets
Early Bird
49.0
AUD
20
General Admission
79.0
AUD
30
General Admission - Last Chance
99.0
AUD
20
Silver Sponsorship
2499.0
AUD
5